Oral Pain Relief Gel
NDC Package 57896-139-05
Package Information
Oral Pain Relief (benzocaine) gel is • do not exceed recommended dosage• do not use for more than 7 days unless told to do so by a dentist or doctor• adults and children 2 years of age or older: apply to affected area up to 4 times daily or as directed by doctor/dentist • children between 2 and 12 years of age: adult supervision should be given in use of this product • children under 2 years of age: do not use. This formulation utilizes a gel delivery system. Marketed by Geri-care Pharmaceutical Corp, this product is identified by NDC 57896-139 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 238910 - benzocaine 20 % Oral Gel
- RxCUI: 238910 - benzocaine 0.2 MG/MG Oral Gel
- RxCUI: 238910 - benzocaine 20 % (180-220 MG per 1 GM) Oral Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57896 - Geri-care Pharmaceutical Corp
- 57896-139 - Oral Pain Relief
- 57896-139-05 - 1 TUBE in 1 CARTON / 14.2 g in 1 TUBE
- 57896-139 - Oral Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57896-139-05 identifies a specific commercial package of 1 tube in 1 carton / 14.2 g in 1 tube of Oral Pain Relief, a human over the counter drug labeled by Geri-care Pharmaceutical Corp. This product is billed per "GM" gram and contains an estimated amount of 14.2 billable units per package. This gel is formulated for oral use and contains benzocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-care Pharmaceutical Corp on March 01, 2021. The current certification is valid through December 31, 2026.
How is this Geri-care Pharmaceutical Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896013905. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 14.2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.